Stratos Wealth Partners LTD. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.9% ...

Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $29,000. Highline Wealth Partners LLC bought a new stake in iShares ...

Earlier this week, the Trump administration froze and then rescinded the freeze on federal funding for several programs, including research funding that the biotech ... and in the ETF space.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange ...

Discover the best brokers for stock trading and ordering other assets! iShares Biotechnology ETF Cert Deposito Arg Repr 0.037037037 Sh Stock Snapshot iShares Biotechnology ETF Cert Deposito Arg ...

BlackRock (BLK) converted its high-yield municipal bond fund into an active exchange-traded fund, creating the iShares High ...

Year-to-date, the iShares Biotechnology ETF return is roughly 4.88% so far, and was up about 3.47% over the last 12 months (as of 02/03/2025). IBB has traded between $124.64 and $149.47 in this past ...